Secondary avascular necrosis
MONDO:0018374Also known as: secondary AVN
37 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Gene therapy may free gaucher patients from lifelong infusions
Disease control Recruiting nowThis Phase 3 trial tests a gene therapy called FLT201 for adults with Gaucher disease type 1. The goal is to see if a single dose can keep blood counts stable so patients can stop their regular enzyme replacement or substrate reduction therapy. The study will enroll 45 people who…
Phase: PHASE3 • Sponsor: Spur Therapeutics • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a simple drug combo heal jaw bone damage?
Disease control Recruiting nowThis phase 2 trial tests whether a combination of pentoxifylline and vitamin E can help heal jaw bone damage caused by certain osteoporosis or cancer drugs. The study will enroll 17 adults with stage 2 medication-related osteonecrosis of the jaw. Researchers will measure how many…
Phase: PHASE2 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for rare clotting disorder: drug aims to prevent dangerous clots during surgery and delivery
Disease control Recruiting nowThis study tests a drug called Atenativ in people with a rare inherited condition that raises their risk of dangerous blood clots. The goal is to see if Atenativ can prevent clots during surgery or childbirth. About 38 adults and some teens will take part. The drug is given as an…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug could help heart surgery patients who Don't respond to standard blood thinner
Disease control Recruiting nowThis study tests a drug called Atenativ, made from human plasma, in 120 adults who are resistant to heparin during planned heart surgery. Heparin is a blood thinner used to prevent clots during surgery, but some patients don't respond well. The drug aims to restore heparin's effe…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Your own stem cells could rebuild a dying hip bone
Disease control Recruiting nowThis study tests a new way to treat early-stage avascular necrosis (bone death) of the hip. Doctors take a patient's own bone marrow stem cells, grow them on a special bone scaffold in the lab, and then implant this 'tissue-engineered bone' into the damaged area. The goal is to s…
Phase: NA • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
One-Time gene therapy could change gaucher treatment forever
Disease control Recruiting nowThis study tests a new gene therapy called LY-M001 for adults with Gaucher disease type 1, a genetic disorder that causes organ damage and other health problems. The therapy uses a harmless virus to deliver a working copy of the GBA1 gene to liver cells, aiming to restore the mis…
Phase: PHASE1, PHASE2 • Sponsor: Lingyi Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Dental implant dilemma: to keep or remove when jaw bone dies?
Knowledge-focused Recruiting nowThis study looks at patients who develop a condition called MRONJ (bone death in the jaw) after taking osteoporosis medications. When this happens around a dental implant, doctors disagree on whether to remove the implant or try to save it. The study will compare healing and bone…
Phase: NA • Sponsor: Kyunghee University Dental Hospital • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
New blood tests could improve gaucher disease monitoring
Knowledge-focused Recruiting nowThis study is looking at new blood markers that measure inflammation and oxidative stress in people with Gaucher disease type 1. Researchers want to see if these markers can give more information than the tests currently used. The study involves 34 adults who are stable on their …
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
New study tracks how cancer surgery affects Kids' walking
Knowledge-focused Recruiting nowThis study looks at how well children walk after having surgery for bone or soft tissue cancer in their legs. Researchers will use 3D cameras, muscle sensors, and wearable devices to measure movement in 300 children, comparing them to healthy kids of the same age. The goal is to …
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can MRI predict radiation side effects before they happen?
Knowledge-focused Recruiting nowThis study uses repeated MRI scans after radiation therapy to see if they can predict normal tissue damage, like bone death (osteoradionecrosis), in patients with oral cavity or skull base tumors. Researchers will track changes in imaging over time and link them to radiation dose…
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Can we predict Parkinson's decades early? new study recruits 600 participants
Knowledge-focused Recruiting nowThis study aims to find early signs of Parkinson's disease in people who carry a change in the GBA1 gene, which puts them at higher risk. Researchers will use simple, non-invasive tests to check for subtle changes in movement, thinking, sleep, and other functions that can appear …
Sponsor: Shaare Zedek Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Cough medicine repurposed: ambroxol registry launches for rare brain diseases
Knowledge-focused Recruiting nowThis study creates a registry to collect real-world information on the safety and effectiveness of ambroxol, a common cough medicine, when used at higher doses for Gaucher disease or GBA-related Parkinson disease. Researchers aim to gather data from 300 patients worldwide who are…
Sponsor: Shaare Zedek Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Are doctors prescribing antithrombin correctly? a new study investigates
Knowledge-focused Recruiting nowThis study looks back at how antithrombin, a blood-clotting protein, was prescribed to 160 intensive care patients at Strasbourg University Hospitals over two years. Researchers want to see if these prescriptions were appropriate and how the drug was used in real-world settings. …
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New 3D camera method could transform facial reconstruction outcomes
Knowledge-focused Recruiting nowThis study aims to develop and validate a new 3D camera technique to objectively measure facial symmetry after reconstructive surgery. Researchers will enroll 50 adults who have had facial reconstruction due to tumor removal, trauma, or other causes. The goal is to identify facto…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Global registry aims to improve jaw reconstruction outcomes
Knowledge-focused Recruiting nowThis study is a registry that will follow at least 300 people who need jaw reconstruction after having part of their jaw removed due to cancer or medication-related bone damage. Researchers will collect information on surgical methods, recovery times, and quality of life to learn…
Sponsor: AO Innovation Translation Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:04 UTC